Related Experiment Video

Updated: Jul 21, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

[Clinical evaluation of cefprozil in children]

Y Mochizuki1, S Kanazashi, D Hata

  • 1Department of Pediatrics, Shizuoka General Hospital.

The Japanese Journal of Antibiotics
|December 1, 1992
PubMed

Insights

Cefprozil (CFPZ) is a new oral cephalosporin antibiotic that demonstrated high efficacy and safety in treating bacterial infections in children. The study found an overall efficacy rate of 90.5% with minimal adverse effects.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology and therapeutics
  • Antimicrobial agents

Background:

  • Bacterial infections pose a significant health concern in pediatric populations.
  • The need for effective and safe oral antibiotics in children is critical.
  • Cephalosporins are a widely used class of antibiotics for bacterial infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of Cefprozil (CFPZ), a new oral cephalosporin, in pediatric patients.
  • To determine the clinical outcomes and microbiological eradication rates of CFPZ treatment.
  • To identify any adverse events associated with CFPZ administration in children.

Main Methods:

  • A clinical trial involving 42 children diagnosed with various bacterial infections.
  • Cefprozil (CFPZ) was administered at daily dosages ranging from 15.3 to 60.0 mg/kg in 3 or 4 divided doses.
  • Clinical efficacy was assessed, and causative organisms were monitored for eradication. Safety was evaluated through laboratory tests and observation of adverse events.

Main Results:

  • An overall efficacy rate of 90.5% was achieved, with 24 excellent, 14 good, and 4 fair responses.
  • Causative organisms were eradicated in 19 out of 28 cases examined.
  • Adverse events were generally mild, including diarrhea in 2 cases and eosinophilia in 2 cases. Slight elevations in S-GOT and S-GPT were noted in one case.

Conclusions:

  • Cefprozil (CFPZ) is a safe and effective new oral antibiotic for treating susceptible bacterial infections in children.
  • The drug demonstrated a high clinical efficacy and a favorable safety profile in the pediatric population.
  • CFPZ represents a valuable therapeutic option for pediatric infectious diseases.

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...